Effectiveness of an E-health Intervention in Patients With Obstructive Sleep Apnoea
1 other identifier
interventional
260
1 country
1
Brief Summary
Obstructive sleep apnoea is a highly burdensome condition that not only impairs function but also confers a risk of cardiovascular disease. This is particularly evident among those who are poorly compliant with continuous positive airway pressure ventilation therapy. In the management of a chronic and frequent pathology such as OSA, it is necessary to have personalized programs that implement new technology-based tools to improve the comprehensive management of the patient in order to reduce the morbidity associated with this disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedMay 10, 2024
May 1, 2024
1.3 years
January 26, 2022
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure
Blood pressure: Blood pressure changes after 3 months of intervention, measured with a holter blood pressure recorder (Spacelabs 90217A, Hertford: UK).
Pre-post (after 3 months of intervention)
Secondary Outcomes (10)
Polysgraphy
Pre-post (after 3 months of intervention)
The Pittsburgh Sleep Quality Inventory (PSQI)
Pre-post (after 3 months of intervention)
Daytime sleepiness assessment
Pre-post (after 3 months of intervention)
Six-minute walk test (6MWT)
Pre-post (after 3 months of intervention)
Empowerment and motivation for change
Pre-post (after 3 months of intervention)
- +5 more secondary outcomes
Study Arms (2)
Experimental group
EXPERIMENTALA pilot study will be conducted for 2 months with a sample of 10 participants, in order to gather initial data to test the algorithm from the eHealth tool. During the QUAN phase the algorithm will provide individualized feedback and responses to the patients based on their different variables analyzed in real-time by the wrist receiver device: cardiovascular parameters, sleep quality and structure of sleep, physical activity, oxygen saturation. The eHealth tool will contain all the educational materials developed by the researchers of the study. Depending on the information received from the electronic wrist device the eHealth tool will make recommendations of educational topics as hygienic-dietary measures, sleep related habits, or physical activity. The information provided in this regard will be dependent upon the subjects' knowledge gaps/beliefs identified in the QUAL phase and the parameters measures by the electronic wrist device in each subject.
Control group
ACTIVE COMPARATORIn the control group, the participants will be provided with the same electronic wrist device and access to the eHeatlh tool as the experimental group. However, the electronic wrist device will not provide feedback based on the parameters of each individual. The information provided by the eHealth tool will be general information from the sleep unit of the Arnau de Vilanova - Santa María Hospital instead of the materials developed from the QUAL phase.
Interventions
The intervention received will be a specific patient education for each subject depending on the parameters assessed by the electronic wrist device in real-time. The recommendation are related to different educational topics as hygienic-dietary measures and sleep related habits, or physical activity.
Eligibility Criteria
You may qualify if:
- Moderate OSA (apnoea-hypoapnoea index (AHI)) of 15-30
- Hypertension diagnosed by 24h-ABPM
- Men and women aged ≥ 18 years
- Spanish and/or Catalan can be read, written, and spoken
- Currently residing in Lleida (Spain)
- Own or have access to mobile phone (Android and IOS)
You may not qualify if:
- Previous diagnosis of OSA / use of CPAP
- Pregnancy
- Body mass index (BMI) below 17
- Subjects undergoing bariatric intervention or on the waiting list for it
- Not being able to fill out questionnaires
- Incapacity to handle technology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitat de Lleidalead
- Institut de Recerca Biomèdica de Lleidacollaborator
- Horizon 2020 - European Commissioncollaborator
Study Sites (1)
Biomedical Research Institure of Lleida
Lleida, 25198, Spain
Related Publications (1)
Valenzuela-Pascual F, Verdejo-Amengual FJ, Martinez-Navarro O, Blanco-Blanco J, El Arab RA, Rubinat-Arnaldo E, Masbernat-Almenara M, Rubi-Carnacea F, Manuel Marti B, Barbe F, Sanchez-de-la-Torre M. Sequential exploratory mixed-method research of an eHealth intervention on blood pressure, sleep quality and physical activity in obstructive sleep apnoea: rationale and methodology of the Moore4Medical trial protocol. BMJ Open Respir Res. 2024 Dec 18;11(1):e001889. doi: 10.1136/bmjresp-2023-001889.
PMID: 39694678DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fran Valenzuela-Pascual, PhD
Biomedical Research Institute of Lleida
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The study will be triple-blind since, due to its nature (intervention using an eHealth tool), it will be possible to blind both the participants, researchers and statisticians. All the subjects (experimental and control) will receive the same electronic wrist device and eHealth tool. While experimental group receive specific information related to the parameters assessed in real time by the wrist device, the control group will receive general information about obstructive sleep apnoea.
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 26, 2022
First Posted
May 19, 2022
Study Start
September 1, 2023
Primary Completion
December 30, 2024
Study Completion
March 30, 2025
Last Updated
May 10, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share